Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

erlotinib-encapsulating irinotecan/riboflavin-containing PEG-based polymer nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

erlotinib

ET
Type Single Compound
Formula C22H23N3O4
Role core
2

irinotecan-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative

AZO-C6-PEG-S-Ir polymer
Type Polymer
Formula
Role layer
3

riboflavin-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative

AZO-C6-PEG-R polymer
Type Polymer
Formula
Role layer

Properties

Applications

Characterization

Biological effects

Biological system Test details Source
female BALB/c nude mice bearing with MCF-7 xenograft tumor

5 more entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • riboflavin-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative
  • erlotinib
  • irinotecan-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative
  1. eVqRCSxWMtWiPjJ6UbC8GBSnBG2B84VvzhpqNOUJKIpM1Jpc1MEwlUtiieG7ygfzBn3
Product

erlotinib-encapsulating irinotecan/riboflavin-containing PEG-based polymer nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial